Cardiac FKBP12.6 overexpression protects against triggered ventricular tachycardia in pressure overloaded mouse hearts

Antoons G, Mubagwa K, Nevelsteen I, Sipido KR (2002) Mechanisms underlying the frequency dependence of contraction and [Ca(2+)](i) transients in mouse ventricular myocytes. J Physiol 543:889–898. doi: 10.1113/jphysiol.2002.025619

Assayag P, Carre F, Chevalier B, Delcayre C, Mansier P, Swynghedauw B (1997) Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I Fibros Cardiovasc Res 34:439–444. doi: 10.1016/S0008-6363(97)00073-4

Belevych AE, Terentyev D, Terentyeva R, Nishijima Y, Sridhar A, Hamlin RL, Carnes CA, Gyorke S (2011) The relationship between arrhythmogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function. Cardiovasc Res 90:493–502. doi: 10.1093/cvr/cvr025

Chelu MG, Danila CI, Gilman CP, Hamilton SL (2004) Regulation of ryanodine receptors by FK506 binding proteins. Trends Cardiovasc Med 14:227–234. doi: 10.1016/j.tcm.2004.06.003

Cheng H, Song LS, Shirokova N, Gonzalez A, Lakatta EG, Rios E, Stern MD (1999) Amplitude distribution of calcium sparks in confocal images: theory and studies with an automatic detection method. Biophys J 76:606–617. doi: 10.1016/S0006-3495(99)77229-2

Colella M, Grisan F, Robert V, Turner JD, Thomas AP, Pozzan T (2008) Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators. Proc Natl Acad Sci USA 105:2859–2864. doi: 10.1073/pnas.0712316105

Elliott EB, Hasumi H, Otani N, Matsuda T, Matsuda R, Kaneko N, Smith GL, Loughrey CM (2011) K201 (JTV-519) alters the spatiotemporal properties of diastolic Ca(2+) release and the associated diastolic contraction during beta-adrenergic stimulation in rat ventricular cardiomyocytes. Basic Res Cardiol 106:1009–1022. doi: 10.1007/s00395-011-0218-4

Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Dworatzek E, Staub E, Martus P, Ruiz Noppinger P, Kintscher U, Gustafsson JA, Regitz-Zagrosek V (2010) Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol 298:R1597–R1606

Gellen B, Fernandez-Velasco M, Briec F, Vinet L, LeQuang K, Rouet-Benzineb P, Benitah JP, Pezet M, Palais G, Pellegrin N, Zhang A, Perrier R, Escoubet B, Marniquet X, Richard S, Jaisser F, Gomez AM, Charpentier F, Mercadier JJ (2008) Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation 117:1778–1786. doi: 10.1161/CIRCULATIONAHA.107.731893

Gergs U, Baumann M, Bockler A, Buchwalow IB, Ebelt H, Fabritz L, Hauptmann S, Keller N, Kirchhof P, Klockner U, Ponicke K, Rueckschloss U, Schmitz W, Werner F, Neumann J (2010) Cardiac overexpression of the human 5-HT4 receptor in mice. Am J Physiol Heart Circ Physiol 299:H788–H798. doi: 10.1152/ajpheart.00691.2009

Gomez AM, Schuster I, Fauconnier J, Prestle J, Hasenfuss G, Richard S (2004) FKBP12.6 overexpression decreases Ca2+ spark amplitude but enhances [Ca2+]i transient in rat cardiac myocytes. Am J Physiol Heart Circ Physiol 287:H1987–H1993. doi: 10.1152/ajpheart.00409.2004

Guo T, Cornea RL, Huke S, Camors E, Yang Y, Picht E, Fruen BR, Bers DM. Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on ca sparks. Circ Res 106:1743–1752. doi: 10.1161/CIRCRESAHA.110.219816

Haworth RS, Cuello F, Avkiran M (2011) Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation. Basic Res Cardiol 106:51–63. doi: 10.1007/s00395-010-0116-1

Huang F, Shan J, Reiken S, Wehrens XH, Marks AR (2006) Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin2 in mice. Proc Natl Acad Sci USA 103:3456–3461. doi: 10.1073/pnas.0511282103

Jayaraman T, Brillantes AM, Timerman AP, Fleischer S, Erdjument-Bromage H, Tempst P, Marks AR (1992) FK506 binding protein associated with the calcium release channel (ryanodine receptor). J Biol Chem 267:9474–9477

Jeyakumar LH, Ballester L, Cheng DS, McIntyre JO, Chang P, Olivey HE, Rollins-Smith L, Barnett JV, Murray K, Xin HB, Fleischer S (2001) FKBP binding characteristics of cardiac microsomes from diverse vertebrates. Biochem Biophys Res Commun 281:979–986. doi: 10.1006/bbrc.2001.4444

Ji Y, Zhao W, Li B, Desantiago J, Picht E, Kaetzel MA, Schultz Jel J, Kranias EG, Bers DM, Dedman JR (2006) Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility. Am J Physiol Heart Circ Physiol 290:H599–H606. doi: 10.1152/ajpheart.00214.2005

Kushnir A, Shan J, Betzenhauser MJ, Reiken S, Marks AR (2010) Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure. Proc Natl Acad Sci USA 107:10274–10279. doi: 10.1073/pnas.1005843107

Lam E, Martin MM, Timerman AP, Sabers C, Fleischer S, Lukas T, Abraham RT, O’Keefe SJ, O’Neill EA, Wiederrecht GJ (1995) A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. J Biol Chem 270:26511–26522. doi: 10.1074/jbc.270.44.26511

Lehnart SE, Terrenoire C, Reiken S, Wehrens XH, Song LS, Tillman EJ, Mancarella S, Coromilas J, Lederer WJ, Kass RS, Marks AR (2006) Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. Proc Natl Acad Sci USA 103:7906–7910. doi: 10.1073/pnas.0602133103

Li N, Wang T, Wang W, Culter MJ, Wang Q, Voigt N, Rosenbaum DS, Dobrev D, Wehrens XH (2011) Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. Circ Res. doi: 10.1161/CIRCRESAHA.111.253229

Lucats L, Vinet L, Bize A, Monnet X, Morin D, Su JB, Rouet-Benzineb P, Cazorla O, Mercadier JJ, Hittinger L, Berdeaux A, Ghaleh B (2007) The inotropic adaptation during late preconditioning against myocardial stunning is associated with an increase in FKBP12.6. Cardiovasc Res 73:560–567. doi: 10.1016/j.cardiores.2006.11.020

Ozdemir S, Bito V, Holemans P, Vinet L, Mercadier JJ, Varro A, Sipido KR (2008) Pharmacological inhibition of na/ca exchange results in increased cellular Ca2+ load attributable to the predominance of forward mode block. Circ Res 102:1398–1405. doi: 10.1161/CIRCRESAHA.108.173922

Prestle J, Janssen PM, Janssen AP, Zeitz O, Lehnart SE, Bruce L, Smith GL, Hasenfuss G (2001) Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. Circ Res 88:188–194. doi: 10.1161/01.RES.88.2.188

Previlon M, Pezet M, Semprez F, Mercadier JJ, Rouet-Benzineb P (2011) FKBP12.6 mice display temporal gender differences in cardiac Ca(2+)-signalling phenotype upon chronic pressure overload. Can J Physiol Pharmacol 89:769–782. doi: 10.1139/Y11-075

Rosen MR (1986) Is the response to programmed electrical stimulation diagnostic of mechanisms for arrhythmias? Circulation 73:II18–II27

Seidler T, Teucher N, Hellenkamp K, Unsold B, Grebe C, Kramps P, Schotola H, Wagner S, Schondube FA, Hasenfuss G, Maier LS (2011) Limitations of FKBP12.6-directed treatment strategies for maladaptive cardiac remodeling and heart failure. J Mol Cell Cardiol 50:33–42. doi: 10.1016/j.yjmcc.2010.08.016

Sossalla S, Maurer U, Schotola H, Hartmann N, Didie M, Zimmermann WH, Jacobshagen C, Wagner S, Maier LS (2011) Diastolic dysfunction and arrhythmias caused by overexpression of CaMKIIdelta(C) can be reversed by inhibition of late Na(+) current. Basic Res Cardiol 106:263–272. doi: 10.1007/s00395-010-0136-x

Timerman AP, Jayaraman T, Wiederrecht G, Onoue H, Marks AR, Fleischer S (1994) The ryanodine receptor from canine heart sarcoplasmic reticulum is associated with a novel FK-506 binding protein. Biochem Biophys Res Commun 198:701–706. doi: 10.1006/bbrc.1994.1101

Toischer K, Lehnart SE, Tenderich G, Milting H, Korfer R, Schmitto JD, Schondube FA, Kaneko N, Loughrey CM, Smith GL, Hasenfuss G, Seidler T (2010) K201 improves aspects of the contractile performance of human failing myocardium via reduction in Ca2+ leak from the sarcoplasmic reticulum. Basic Res Cardiol 105:279–287. doi: 10.1007/s00395-009-0057-8

Toischer K, Rokita AG, Unsold B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lehnart SE, Kruger M, Linke WA, Backs J, Regitz-Zagrosek V, Schafer K, Field LJ, Maier LS, Hasenfuss G (2010) Differential cardiac remodeling in preload versus afterload. Circulation 122:993–1003. doi: 10.1161/CIRCULATIONAHA.110.943431

Vaidya D, Morley GE, Samie FH, Jalife J (1999) Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis. Circ Res 85:174–181

van Oort RJ, Respress JL, Li N, Reynolds C, De Almeida AC, Skapura DG, De Windt LJ, Wehrens XH (2010) Accelerated development of pressure overload-induced cardiac hypertrophy and dysfunction in an RyR2-R176Q knockin mouse model. Hypertension 55:932–938. doi: 10.1161/HYPERTENSIONAHA.109.146449

van Rijen HV, van Veen TA, Gros D, Wilders R, de Bakker JM (2006) Connexins and cardiac arrhythmias. Adv Cardiol 42:150–160. doi: 10.1159/000092567

Vinet L, Rouet-Benzineb P, Marniquet X, Pellegrin N, Mangin L, Louedec L, Samuel JL, Mercadier JJ (2008) Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction. Am J Physiol Heart Circ Physiol 295:H352–H360. doi: 10.1152/ajpheart.01101.2007

Vos MA, Gorgels AP, Leunissen JD, van Deursen RT, Wellens HJ (1991) Significance of the number of stimuli to initiate ouabain-induced arrhythmias in the intact heart. Circ Res 68:38–44

Wehrens XH, Lehnart SE, Reiken SR, Deng SX, Vest JA, Cervantes D, Coromilas J, Landry DW, Marks AR (2004) Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304:292–296. doi: 10.1126/science.1094301

Wu X, Zhang T, Bossuyt J, Li X, McKinsey TA, Dedman JR, Olson EN, Chen J, Brown JH, Bers DM (2006) Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 116:675–682. doi: 10.1172/JCI27374

Wu Y, Gao Z, Chen B, Koval OM, Singh MV, Guan X, Hund TJ, Kutschke W, Sarma S, Grumbach IM, Wehrens XH, Mohler PJ, Song LS, Anderson ME (2009) Calmodulin kinase II is required for fight or flight sinoatrial node physiology. Proc Natl Acad Sci USA 106:5972–5977. doi: 10.1073/pnas.0806422106

Xin HB, Senbonmatsu T, Cheng DS, Wang YX, Copello JA, Ji GJ, Collier ML, Deng KY, Jeyakumar LH, Magnuson MA, Inagami T, Kotlikoff MI, Fleischer S (2002) Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 416:334–338. doi: 10.1038/416334a

Yu Z, Redfern CS, Fishman GI (1996) Conditional transgene expression in the heart. Circ Res 79:691–697

Zou Y, Liang Y, Gong H, Zhou N, Ma H, Guan A, Sun A, Wang P, Niu Y, Jiang H, Takano H, Toko H, Yao A, Takeshima H, Akazawa H, Shiojima I, Wang Y, Komuro I, Ge J (2011) Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy. Hypertension 58:1099–1110. doi: 10.1161/HYPERTENSIONAHA.111.173500